|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-23-310228 |
H00000369-D01P |
A RAF Antibody//Human/Rabbit |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
A RAF Antibody |
Description
|
/ Human/Rabbit |
Clonality
|
Poly |
Company
|
Novus biologicals |
Application
|
ELISA, Western Blot |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description:Summary: Species: | Hu | Applications: | ELISA, WB | Clonality: | Polyclonal | | Gene: | ARAF | Purity: | protein A purified | Host: | Rabbit | | Specificity: | ARAF - v-raf murine sarcoma 3611 viral oncogene homolog, | Details: Immunogen: | ARAF (NP_001645.1, 1 a.a. ~ 606 a.a) full-length human protein. | Epitope: | MEPPRGPPANGAEPSRAVGTVKVYLP NKQRTVVTVRDGMSVYDSLDKALKVR GLNQDCCVVYRLIKGRKTVTAWDTAI APLDGEELIVEVLEDVPLTMHNFVRK TFFSLAFCDFCLKFLFHGFRCQTCGY KFHQHCSSKVPTVCVDMSTNRQQFYH SVQDLSGGSRQHEAPSNRPLNELLTP QGPSPRTQHCDPEHFPFPAPANAPLQ RIRSTSTPNVHMVSTTAPMDSNLIQL TGQSFSTDAAGSRGGSDGTPR | Gene Symbol: ARAF Entrez: | 369 (Human) | Swiss Prot: | NP_001645.1 (Human) | Related Genes: | RAF1, ZHX2, BRAF, NDUFAB1, SNRPE, FASN, OXSM, MAPK1, EPHB2, FAS, MAP2K1, PIK3CG, LYST, MAPK3, TIMP1, SHBG, ABP1, MCAT, EGF, GALP, AKT1, SRC, GLYAT, SYN1, CAT, TH1L, C3orf39, CFP, CYP19A1, PKC, MAP3K1, FOS, PIK3CA, PIK3CB, PIK3CD, A4GALT, HSP90AA1, RRAS2, KCNH8, CDKN1A | Species: Applications: Uses: | Antibody reactive against recombinant protein with GST tag on ELISA and western blot and also on transfected lysate in western blot. GST tag alone is used as a negative control. | Dilutions: | Western Blot 1:500,ELISA | Notes: This product is produced by and distributed for Abnova, a company based in Taiwan. Packaging: Storage: | Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | Preservative: | No Preservative | Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. | |
|
|
|
|